non-gonococcal urethritis (NGU)
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Localized Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
8
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Acquired thrombophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
8
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Castration-Sensitive Prostate Carcinoma
|
disease |
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Advanced Prostate Carcinoma
|
disease |
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Urinary symptoms
|
phenotype |
|
Sign or Symptom
|
10
|
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2019 |
Polyglandular Type III Autoimmune Syndrome
|
disease |
Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
CYP2C19 polymorphism
|
disease |
|
Disease or Syndrome
|
10
|
4
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Adenocarcinoma of the prostate metastatic
|
disease |
|
Neoplastic Process
|
11
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Residual Cancer
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Locally Advanced Malignant Neoplasm
|
disease |
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Blood in stool
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Sign or Symptom
|
13
|
2
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Autoimmune Syndrome Type II, Polyglandular
|
disease |
Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
14
|
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2011 |
Uncontrolled hypertension
|
disease |
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Infarction of spinal cord
|
disease |
Nervous System Diseases; Cardiovascular Diseases; Wounds and Injuries
|
Disease or Syndrome
|
14
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Chronic ulcer
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Scott Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
hormone-resistant prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
16
|
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2013 |
Dysuria
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
17
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Non-metastatic prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
18
|
|
0.100 |
None |
1.000 |
13 |
|
2017 |
2020 |
Bacteriuria
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Recurrent Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Chronic prostatitis
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
20
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Urinary Bladder, Underactive
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
20
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Secondary hypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
22
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |